Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation
2019 · Nature Communications · 186 citations
https://doi.org/10.1038/s41467-018-08201-x
A
Agnieszka Czechowicz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
89
Papers
2.2K
Citations
19
h-index
23
i10-index
Agnieszka Czechowicz is an academic researcher from California Institute for Regenerative Medicine. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & DNA Repair Mechanisms & CRISPR and Genetic Engineering. The author has an h-index of 19, co-authored 76 publications.
ORCID: 0000-0003-2909-2669Papers by this author
worksDevelopment of multivalent CAR T cells as dual immunotherapy and conditioning agents
2025 · Molecular Therapy Oncology · 8 citations
https://doi.org/10.1016/j.omton.2025.200944
Targeted hematopoietic stem cell depletion through SCF-blockade
2024 · Stem Cell Research & Therapy · 2 citations
https://doi.org/10.1186/s13287-024-03981-0
Attitudes Toward Prenatal Interventions in the Fanconi Anemia Community
2026 · Prenatal Diagnosis · 0 citations
https://doi.org/10.1002/pd.70077
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat